Bard May Not Tout Hernia Mesh Products as ‘Lifesaving’ During Bellwether Trial



DOCUMENTS
  • Order


COLUMBUS, Ohio — An Ohio federal judge has ruled that C.R. Bard may not tout its Ventralight ST hernia mesh as a “lifesaving device” in an upcoming bellwether trial, agreeing with the plaintiff that such a characterization is not supported by reliable data.

In a Dec. 3 order, Judge Edmund A. Sargus of the U.S. District Court for the Southern District of Ohio further ruled that Bard may present percentages or comparative analysis of adverse events at the April 19 trial, but only through a qualified witness.

The Food and Drug Administration cleared the Ventralight ST device for use through …






UPCOMING CONFERENCES




HarrisMartin's Webinar Series: New Jersey Asbestos Litigation

February 11, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS



HarrisMartin's Webinar Series: Benzene Litigation - Using Genomics in the Courtroom

February 18, 2021 - Haddonfield, NJ
HarrisMartin Webinar Series

MORE DETAILS